Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression

Xuan Wang,Yue-Hua Li,Ming-Hua Li,Jing Lu,Jun-Gong Zhao,Xiao-Jiang Sun,Bin Zhang,Jian-Lin Ye

DOI: https://doi.org/10.1007/s00406-011-0209-3

2011-01-01

European Archives of Psychiatry and Clinical Neuroscience

Abstract:In recent studies, the glutamate (Glu) level has been quantified using the modified STEAM sequence on 3T MRI. We enrolled 15 healthy volunteers and a group of 51 patients who experienced stroke for the first time and had a good prognosis. The patients with infarction were divided into three groups according to their scores by using the DSM-IV diagnostic criteria for major depressive disorder and the 17-item Hamilton Depression Rating Scale (HDRS). We studied the association between post-stroke depression and 1 H-MRS measurements in unaffected frontal lobes. Single-voxel proton magnetic resonance spectroscopy ( 1 H-MRS) was performed to assess N -acetylaspartate/creatine (NAA)/Cr, (Glu)/Cr, choline (Cho)/Cr, and myoinositol (mI)/Cr ratios in stroke patients. The 11 patients (21.5%) who met the criteria for depression and 9 patients (17.6%) who had a high score for HDRS, (>14) but were not depressed, had a significantly higher Glu/Cr ratio than patients who scored ≤14 on HDRS and control groups ( p < 0.001). No differences were found in NAA/Cr, Cho/Cr, or mI/Cr between the groups after stroke. These findings suggest that post-stroke depression is accompanied by changes in glutamate levels in the frontal lobe.